Top Life Science Tools and Services Stocks to Buy Now and Keep –

0

The life sciences sector is booming, with innovations in precision medicine and other fields driving the growth of the global bio healthcare industry. Companies that provide the tools and services that help scientists conduct research more efficiently and cost-effectively also benefit from this research boom. These companies will continue to see their stock prices rise as long as investors remain optimistic about the future of the life sciences market. To help you get started investing, here are some of the top life science tools and services stocks to buy now and hold for the long term.

NeoGenomics (NEO)

Investors like NeoGenomics because it’s a pure play on the growing popularity of next-generation sequencing. As the name suggests, Next Generation Sequencing is a more advanced and affordable sequencing technique than its predecessors. Scientists must use specialized sequencing equipment to perform DNA sequencing and other genetic material. More advanced sequencing techniques are also developing for other types of medical tests, such as cancer screening. As sequencing becomes more mainstream, the demand for sequencing equipment will increase. This means that companies like NeoGenomics that manufacture sequencing equipment will see their sales and share price increase. Beyond the strength of its core business, NeoGenomics also has several other positive factors in its favour, including its low leverage and available cash. The company has also increased its dividend payout, which is an additional source of income for long-term investors. These factors make NeoGenomics an excellent long-term investment choice.

Bio-Rad Laboratories (BIO)

Bio-Rad Laboratories manufactures a wide range of laboratory equipment and supplies, including high-end instruments, essential laboratory equipment and consumables, and robotic systems. This company has several products that are the benchmark in the industry, including its Bio-Plex system, a technique for high-throughput screening of biological samples. Bio-Rad Laboratories also recently completed a restructuring aimed at making the company more streamlined and efficient. This restructuring has increased the company’s cash flow and profitability, making it an excellent choice for long-term investment. Beyond that, Bio-Rad Laboratories is also experiencing revenue growth. The company has aggressively expanded internationally, which should help increase sales and profits in the years to come. Bio-Rad Laboratories also has a strong balance sheet, enabling it to fund future growth and acquisitions. It also pays a dividend, an added benefit for long-term investors.

ICON plc (ICLR)

ICON plc manufactures a wide range of laboratory equipment and supplies including high throughput sequencers, DNA and RNA synthesizers, liquid chromatography systems and atomic force microscopes. The company also provides consulting and support services for the scientific instrumentation industry. ICLR offers several industry-leading products that set the gold standard, including its HiSeq X Ten sequencer, the world’s most comprehensive DNA sequencing system. ICLR also recently acquired a company specializing in analytical instruments, adding to its product portfolio. Beyond its robust product line, ICLR has several other advantages, including a strong balance sheet and healthy cash flow. In addition, the company focused on cost reduction, which helped increase its profitability. ICLR also pays a dividend, an added benefit for long-term investors.

Bruker (BRKR)

Bruker is a leading supplier of scientific instruments in the life sciences, materials science and chemistry. The company has a comprehensive product portfolio, including laboratory equipment such as high-end mass spectrometers and microscopes, as well as science experiment management software. Bruker also has a growing portfolio of products for emerging areas of semiconductors and quantum technologies. The company recently acquired a quantum computing company and agreed to acquire an Austrian materials testing company. Beyond its core business, Bruker has several other advantages, including a strong balance sheet and healthy cash flow. The company also focused on cost reduction, which helped increase its profitability. Bruker also pays a dividend, an added benefit for long-term investors. Investors optimistic about the long-term future of the life sciences industry can benefit from investing in stocks of companies that provide the tools and services that help scientists conduct more efficient and profitable research. These companies will continue to see their stock prices rise as long as investors remain optimistic about the future of the life sciences market.


Source link

Share.

Comments are closed.